Guerbet S.A.
GUERF
Get informed when a big investor buys or sells
+ FollowMarket Cap$281.03M
Close$
Share Statistics
| Market cap | $281.03 Million |
|---|---|
| Enterprise Value | $622.82 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $1.28 |
| Beta | 0.69 |
| Outstanding Shares | 12,603,500 |
Return
| Return on Equity | 10.13% |
|---|---|
| Return on Assets | 3.85% |
| Return on Invested Capital | 10.89% |
Valuation & Multiples
| P/E Ratio | -0.58 |
|---|---|
| PEG | 0.76 |
| Price to Sales | 0.17 |
| Price to Book Ratio | 0.72 |
| Enterprise Value to Revenue | 0.38 |
| Enterprise Value to EBIT | 7.31 |
| Enterprise Value to Net Income | 15 |
| Total Debt to Enterprise | 0.63 |
| Debt to Equity | 0.99 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Guerbet S.A.
2,746 employees
CEO: Karim Boussebaa Guerbet S.A. is a medical technology company focused on the innovation and commercialization of contrast media products, specialized delivery systems, medical devices, and related solutions. Its comprehensive portfolio includes a range o...